No Prescription |
 |
 | ||
|
NovoRapid NovoLog |
|
| ||
No Prescription » Prescription Drugs 12 » NovoRapid NovoLog Medical Information:Insulin is a hormone that is produced in the body. It works by lowering levels of glucose (sugar) in the blood. Insulin aspart is a fast-acting form of insulin.Insulin aspart is used to treat type 1 (insulin-dependent) diabetes in adults. It is usually given together with another long-acting insulin.Insulin aspart (IN-su-lin AS-part)is a fast-acting type of human insulin. Insulin is used by people type 2 diabetes to help keep blood sugar levels under control. If you have type 2 diabetes your body cannot make enough or does not use insulin properly. So you must take additional insulin to regulate your blood sugar and keep your body healthy. This is very important as too much sugar in your blood can be harmful to your health. Since insulin aspart acts faster than regular human insulin you normally should use insulin aspart with a longer-acting insulin. Buy NovoRapid NovoLog and other Prescription Drugs 12 products online at Medstore. 3702
About NovoRapid NovoLog: Product Type: Prescription Drugs 12 NovoRapid ( NovoLog NovoLog FlexPen NovoLog PenFill Generic Insulin Aspart (rDNA) ) NovoRapid (NovoLog NovoLog FlexPen NovoLog PenFill Generic Insulin Aspart) NovoLog NovoLog FlexPen NovoLog PenFill Generic Insulin Aspart 3ml 5 Cartridges NovoLog NovoLog FlexPen NovoLog PenFill Generic Insulin Aspart NovoRapid
View more Prescription Drugs 12 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
